INSMED INC's ticker is and the CUSIP is 457669AA7. A total of 24 filers reported holding INSMED INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $4,000 | -71.4% | 15,324 | -69.0% | 0.00% | – |
| Q3 2021 | $14,000 | -33.3% | 49,366 | -34.2% | 0.00% | – |
| Q2 2021 | $21,000 | -73.1% | 75,032 | -67.2% | 0.00% | – |
| Q1 2021 | $78,000 | +151.6% | 228,415 | +147.6% | 0.00% | – |
| Q4 2020 | $31,000 | +14.8% | 92,270 | +11.1% | 0.00% | – |
| Q3 2020 | $27,000 | -18.2% | 83,076 | -31.1% | 0.00% | – |
| Q2 2020 | $33,000 | -2.9% | 120,490 | -43.3% | 0.00% | – |
| Q1 2020 | $34,000 | -99.0% | 212,607 | -98.6% | 0.00% | -100.0% |
| Q4 2019 | $3,576,000 | -11.2% | 15,000,000 | -35.7% | 0.01% | -13.3% |
| Q3 2019 | $4,025,000 | – | 23,338,000 | -40.6% | 0.02% | – |
| Q2 2019 | $0 | – | 39,290,000 | +291.1% | 0.00% | – |
| Q1 2019 | $0 | – | 10,045,000 | -49.9% | 0.00% | – |
| Q4 2018 | $0 | – | 20,063,000 | +5.6% | 0.00% | – |
| Q3 2018 | $0 | – | 19,000,000 | +120.6% | 0.00% | – |
| Q2 2018 | $0 | – | 8,613,000 | -56.9% | 0.00% | – |
| Q1 2018 | $0 | – | 20,000,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Worth Venture Partners, LLC | 2,974,000 | $2,536,000 | 1.90% |
| Mohican Financial Management, LLC | 500,000 | $422,000 | 1.47% |
| LINDEN ADVISORS LP | 51,146,000 | $43,311,000 | 1.32% |
| ZAZOVE ASSOCIATES LLC | 15,101,000 | $12,810,000 | 1.11% |
| DLD Asset Management, LP | 24,500,000 | $20,911,000 | 1.03% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 31,749,000 | $26,863,000 | 0.55% |
| Cheyne Capital Management (UK) LLP | 1,000,000 | $853,000 | 0.51% |
| SSI INVESTMENT MANAGEMENT LLC | 6,000,000 | $5,050,000 | 0.39% |
| Jabre Capital Partners S.A. | 1,100,000 | $943,000 | 0.31% |
| Orbimed Advisors | 26,500,000 | $22,611,000 | 0.27% |